Position in DHR
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$8,408,739
-$1,157,149 QoQ
Shares Held
44,145
-12.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#506
of 2,098 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Avanza Fonder AB holds $36,107,844 across 10 Diagnostics & Research names. DHR ranks #2 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
27,365 | $13,719,715 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
44,145 | $8,408,739 | |
| 3 | A |
Agilent Technologies, Inc.
|
29,831 | $3,962,451 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
5,175 | $2,724,326 | |
| 5 | WAT |
Waters Corp /De/
|
5,389 | $2,021,089 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
7,644 | $1,476,973 | |
| 7 | ILMN |
Illumina, Inc.
|
7,878 | $1,385,188 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1,010 | $1,290,284 |
All Filings in DHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,408,739 | 44,145 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $9,565,888 | 50,453 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $10,540,162 | 46,043 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $9,128,484 | 46,043 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $8,432,784 | 42,689 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $8,822,175 | 43,035 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $10,989,935 | 47,876 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||